WILEY Each year in the United States, nearly 50,000 women are diagnosed with ductal carcinoma in situ (DCIS), a non-invasive breast condition that cannot spread. New research published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society, indicates that many women with DCIS experience confusion and distress about their diagnosis and treatment. In situ...
Tag: <span>ductal carcinoma</span>
Post
Sentinel lymph node biopsy has no benefits for stage zero breast cancer
YALE UNIVERSITY New Haven, Conn. — Older women with a very early, non-invasive breast cancer known as ductal carcinoma in situ (DCIS) gain no long-term benefit from undergoing a sentinel lymph node biopsy to see if the cancer has spread, new research by the Yale School of Public Health has found. The study, believed to be the first to examine the long-term impact of sentinel lymph node biopsies on thousands of older women, found...